Rock Springs Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Treeline Biosciencestreeline.bioSep 2025
Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Joshua H. Bilenker(Executive Officer, Director, Promoter)Jeffrey Engelman(Executive Officer, Director, Promoter)inJosh Bilenker(Founder)in
BoardKristina Burow(Director)inAli Satvat(Director)David Schenkein(Director)in
Co-investorsAisling CapitalARCH Venture PartnersOrbiMedCasdin CapitalFidelity InvestmentsGV (Google Ventures)+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.